News

Chris Brittain, MBBS, BSc, MBA, MRCOphth, vice president and global head of ophthalmology product development for Genentech, provides an overview of the company’s podium presentations from the PDS with ranibizumab to faricimab.

Prof. Marie-José Tassignon, past chief and chair, Department of Ophthalmology, Antwerp University and University Hospital Antwerp, Belgium, expands on her upcoming AAO presentation by providing an overview of her novel technique in performing a risk-free posterior capsulorhexis.

Anne L. Coleman, MD, president of the American Academy of Ophthalmology, offers a preview of its virtual 2020 annual meeting. The AAO is rising to meet the challenges of staging a large-scale event in a virtual setting.

The Ophthalmology Times Resident Writers Award Program is a competitive writing program showcasing the best case studies in anterior segment.

Algorithm detects, stratifies severity of disease, facilitates early diagnosis.

The curators of the American Academy of Ophthalmology’s (AAO) Truhlsen-Marmor Museum of the Eye have been toiling diligently despite the COVID-19 pandemic. So, when opening day does arrive, the results will be eye-opening.

The eye health community is sounding the alarm that the COVID-19 pandemic could worsen the epidemic of children at risk of nearsightedness.

DME diagnosis plays no role in determining whether patients will receive injection.

A Phase 3 clinical trial of NCX 470 will evaluate the drug for the lowering of IOP in patients with open-angle glaucoma or ocular hypertension.

Pfizer Inc. and BioNTech SE this week announced their mRNA-based coronavirus vaccine candidate has demonstrated evidence of efficacy against COVID-19 in participants without evidence of infection.

The University of California San Francisco this week debuted the UCSF Wayne and Gladys Valley Center for Vision, bringing its vision care and research facilities under one roof.

Optics block out-of-focus and stray light, allow continuum of vision.

Device allows visually impaired to recognize shapes, distinguish between light and dark.

Research could lead to a novel therapeutic strategy for blinding disease

The program is dedicated to the education of fellows and residents and offers a unique opportunity to share notable retina research with peers and mentors.

Study examines use of fluocinolone acetonide for treating DME in patients.

Cutting-edge solutions are emerging in healthcare that streamline data capture through a user-friendly interface, leading to an increase in quality and accuracy of data collection while freeing physicians to spend more time with patients.

Study shows improvements in signs, symptoms after 3 months of treatment

New paradigm-changing treatments for young patients on the horizon.

Check out the latest cartoon!

Interest stems from the recognition that the number of people affected with cataracts is expected to increase in association with population aging while access to cataract surgery is limited in areas throughout the world.

Investigators suggest incorporating an examination for mites as part of the preoperative evaluation.

Considerations in the treatment of diabetic retinopathy and diabetic macular edema.

Investigators research safety, efficacy of endolaserless vitrectomy.

The year 2020 dished up a November surprise with a tie between Bascom Palmer Eye Institute and the Wilmer Eye Institute at the top of the rankings for Best Overall Program in the Ophthalmology Times® Best Program Survey.

Using active learning approach can help gauge visual function loss in patients

Congress paused Medicare sequester cuts to offer relief amid the pandemic. Now, the leaders of the American Medical Association, American Hospital Association, American Health Care Association, and National Association for Home Care & Hospice are urging congressional leadership to keep the pause in place.